A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To determine the most cost-effective method of screening for atrial fibrillation (AF) in the population aged 65 years and over, as well as its prevalence and incidence in this age group. Also to evaluate the relative cost-effectiveness of different methods of recording and interpreting the electrocardiogram (ECG) within a screening programme. DESIGN: Multicentred randomised controlled trial. Purposefully selected general practices were randomly allocated to 25 intervention practices and 25 control practices. SETTING: Fifty primary care centres across the West Midlands, UK. PARTICIPANTS: Patients aged 65 years and over. INTERVENTIONS: GPs and practice nurses in the intervention practices received education on the importance of AF detection and ECG interpretation. Patients in the intervention practices were randomly allocated to systematic (n = 5000) or opportunistic screening (n = 5000). Prospective identification of pre-existing risk factors for AF within the screened population enabled comparison between targeted screening of people at higher risk of AF and total population screening. MAIN OUTCOME MEASURES: AF detection rates in systematically screened and opportunistically screened populations in the intervention practices were compared with AF detection rate in 5000 patients in the control practices. The screening period was 12 months. RESULTS: Baseline prevalence of AF was 7.2%, with a higher prevalence in males (7.8%) and patients aged 75 years and over (10.3%). The control population demonstrated higher baseline prevalence (7.9%) than either the systematic (6.9%) or opportunistic (6.9%) intervention population. In the control population 47 new cases were detected (incidence 1.04% per year). In the opportunistic arm 243 patients without a baseline diagnosis of AF were found to have an irregular pulse, with 177 having an ECG, yielding 31 new cases (incidence 0.69% per year). A further 44 cases were detected outside the screening programme (overall incidence 1.64% per year). In the systematic arm 2357 patients had an ECG yielding 52 new cases (incidence 1.1% per year). Of these, 31 were detected by targeted screening and a further 21 by total population screening. A further 22 cases were detected outside the screening programme (overall incidence 1.62% per year). In terms of ECG interpretation, computerised decision support software (CDSS) gave a sensitivity of 87.3%, a specificity of 99.1% and a positive predictive value (PPV) of 89.5% compared with the gold standard (cardiologist reporting). GPs and practice nurses performed less well. The only difference in performance between intervention populations and controls was that practice nurses from the control arm performed less well than with intervention practice nurses on interpretation of limb-lead (PPV 38.8% versus 20.8%) and single-lead (PPV 37.7% versus 24.0%) ECGs. The within-trial economic evaluation results showed the lowest incremental cost to be for the opportunistic arm, with an incremental cost-effectiveness ratio of 337 pounds Sterling for each additional case detected compared to the control arm. Opportunistic screening dominated both more intensive screening strategies. Model-based analyses showed small differences in cost and quality-adjusted life-years for different methods and intensities of screening, but annual opportunistic screening resulted in the lowest number of ischaemic strokes and greatest proportion of cases of AF diagnosed. Probabilistic sensitivity results indicated that there was a probability of approximately 60% that screening from the age of 65 years was cost-effective in both men and women. CONCLUSIONS: The results of the study indicated that in terms of a screening programme for atrial fibrillation in patients 65 and over, the only strategy that improved on routine practice was opportunistic screening, model-based analyses indicated that there was a probability of approximately 60% of annual opportunistic screening being cost effective. It is suggested that the following topics are worthy of further investigation: the effect of the implementation of a screening programme for AF on the uptake and maintenance of anticoagulation in patients aged 65 years and over; an evaluation of the role of CDSS in the diagnosis of cardiac arrythmias; the best method for routinely detecting paroxysmal AF; ways of improving healthcare professionals' performance in ECG interpretation; development of a robust economic model to incorporate data on new therapeutic agents for use as thromboprophylactic agents for patients with AF, and an evaluation of the relative risk of stroke for patients with incident as opposed to prevalent AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“reports of other screening instruments have suggested minimal burden and disruption of the clinical workflow.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [460]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A data monitoring committee will often comprise members from a variety of disciplines.363 451 452”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
Experimental — accuracy not yet measuredIn the citing paper
“Blinding of data monitoring committee members is generally discouraged.363”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
In the citing paper
“Independence, particularly from the sponsor and trial investigators, is a key characteristic of the data monitoring committee and can be broadly defined as the committee comprising members who are “completely uninvolved in the running of the trial and who cannot be unfairly influenced (either directly or indirectly) by people, or institutions, involved in the trial.”363 452”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
In the citing paper
“Opportunistic screening for silent AF seems cost-effective in elderly populations (e.g.> 65 years), 131 and similar effects have been reported using single-lead ECG screening in other at-risk populations.132,133”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Marteau, T. M., & Bekker, H. (1992) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1992.tb00997.x · Cited by 3,238
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,274
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Principles and Practice of Screening for Disease.
Zavon, M. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130131020 · Cited by 1,356
Research works printed but not linked: 16
- [10]10. Lake RR, Cullen KJ, deKlerk NH, McCall MG, Rosman DL. Atrial fibrillation in an elderly population. Aust N Z J Med 1989;19:321-6.
- [11]11. Philips SJ, Whisnant J, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-59.
- [15]15. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
- [19]19. Laupacis A, Albers G, Connolly S. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-57.
- [23]23. Albers GW. Atrial fibrillation and stroke. Arch Intern Med 1994;154:1443-8.
- [24]24. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low- intensity, fixed-dose warfarin plus aspirin for high- risk patients with atrial fibrillation: Stroke References Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-8.
- [34]34. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomised trials. Arch Intern Med 1997;157:1237-40.
- [35]35. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. Ann Intern Med 1992;116:6-12.
- [38]38. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost effectiveness analysis in medicine and health. Oxford: Oxford University Press; 1996.
- [41]41. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiological features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
- [44]44. Hobbs FDR. Should all patients with atrial fibrillation be assessed by a cardiologist? Plenary session. Proceedings from Consensus Conference on the Management of Atrial Fibrillation. Edinburgh: RCP Edinburgh; 1998.
- [57]57. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer MD. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001;285:2370-5.
- [60]60. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-6. J Neurol Neurosurg Psychiatry 1990;53:16-22.
- [63]63. Office for National Statistics. Health Statistics Quarterly, 22. London: Office for National Statistics; 2004.
- [67]67. Robinson A, Thomson R, Parkin D, Sudlow M, Eccles M. How patients with atrial fibrillation value different health outcomes. Journal of Health Services and Research Policy 2001;6:92-8. References
- [73]73. Gray JAM. Dimensions and definitions of screening. Milton Keynes: NHS Executive Anglia; Oxford: Research and Development Directorate; 1996.
Cited by
Items 101–200 of 437
A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
Levin, L.-A., Husberg, M., Sobocinski, P. D., Kull, V. F., Friberg, L., Rosenqvist, M., & Davidson, T. (2015) · Europace · doi:10.1093/europace/euu213 · Cited by 56
Kahwati, L. C., Asher, G. N., Kadro, Z. O., Keen, S., Ali, R., Coker‐Schwimmer, E., & Jonas, D. E. (2022) · JAMA · doi:10.1001/jama.2021.21811 · Cited by 64
Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis
Petryszyn, P., Niewinski, P., Staniak, A., Piotrowski, P., Well, A., Well, M., Jeskowiak, I., Lip, G., & Ponikowski, P. (2019) · PLOS ONE · doi:10.1371/journal.pone.0213198 · Cited by 57
Self-citationAtrial Fibrillation Detection and Management in Hypertension
Gawalko, M. M., & Linz, D. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19459 · Cited by 69
Sharma, P., Scotland, G., Cruickshank, M., Tassie, E., Fraser, C. M., Burton, C. D., Croal, B. L., Ramsay, C. R., & Brazzelli, M. G. (2015) · Health Technology Assessment · doi:10.3310/hta19480 · Cited by 57
Wang, Y.-C., Xu, X., Hajra, A., Apple, S. J., Kharawala, A., Duarte, G., Liaqat, W., Fu, Y., Li, W., Chen, Y., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12030689 · Cited by 65
Newer technologies for detection of atrial fibrillation
Zungsontiporn, N., & Link, M. S. (2018) · BMJ · doi:10.1136/bmj.k3946 · Cited by 53
Harwood, R. H., Goldberg, S. E., Brand, A., van Der Wardt, V., Booth, V., Di Lorito, C., Hoare, Z., Hancox, J., Bajwa, R., Burgon, C., et al. (2023) · BMJ · doi:10.1136/bmj-2023-074787 · Cited by 53
Taggar, J., Coleman, T. J., Lewis, S., Heneghan, C. J., & Jones, M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.014 · Cited by 53
Sekelj, S., Sandler, B. C., Johnston, E., Pollock, K. G., Hill, N. R., Gordon, J. P., Tsang, C., Khan, S. N., Ng, F. S., & Farooqui, U. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320942338 · Cited by 55
Ng, K. H., Hart, R. G., & Eikelboom, J. W. (2013) · Cardiology and Therapy · doi:10.1007/s40119-013-0019-y · Cited by 54
Hall, A., Mitchell, A. R. J., Wood, L., & Holland, C. (2020) · Medicine · doi:10.1097/md.0000000000021388 · Cited by 55
Bakhai, A., Darius, H., Caterina, R. D., Smart, A., Heuzey, J. L., SCHILLING, R. J., Zamorano, J. L., Shah, M., Bramlage, P., & Kirchhof, P. F. (2016) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw031 · Cited by 56
Langley, P., Dewhurst, M. J., Marco, L. Y. D., Adams, P. C., Dewhurst, F., Mwita, J. C., Walker, R., & Murray, A. (2012) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2012.02.002 · Cited by 48
2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening
Chan, N., Orchard, J. J., Agbayani, M. F., Boddington, D., Chao, T., Johar, S., John, B., Joung, B., Krishinan, S., Krittayaphong, R., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12669 · Cited by 57
Surgical treatment of atrial fibrillation: an updated review
Pinho‐Gomes, A., Amorim, M. J., Oliveira, S. M., & Leite-Moreira, A. F. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt584 · Cited by 48
Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke
Thijs, V. (2017) · Stroke · doi:10.1161/strokeaha.117.017083 · Cited by 49
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.004 · Cited by 44
Self-citationBeing precise with anticoagulation to reduce adverse drug reactions: are we there yet?
Cross, B., Turner, R. M., Zhang, E. J., & Pirmohamed, M. (2024) · The Pharmacogenomics Journal · doi:10.1038/s41397-024-00329-y · Cited by 48
Lip, G. Y. H., Skjøth, F., Nielsen, P. B., & Larsen, T. B. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.09.034 · Cited by 47
Self-citationAndersson, P., Löndahl, M., Abdon, N., & Terént, A. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02519.x · Cited by 42
Atrial fibrillation in aging population
Chen, Q., Zhong, Y., & Cheng, J. (2018) · Aging Medicine · doi:10.1002/agm2.12015 · Cited by 48
Screening for atrial fibrillation: sensitivity and specificity of a new methodology
Lewis, M., Parker, D., Weston, C., & Bowes, M. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x548956 · Cited by 41
Hill, N. R., Sandler, B., Mokgokong, R., Lister, S., Ward, T., Boyce, R., Farooqui, U., & Gordon, J. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2019.1706543 · Cited by 38
Zou, H., Zhang, Y., Tong, J., & Liu, Z. (2015) · Internal Medicine Journal · doi:10.1111/imj.12862 · Cited by 36
Identification, diagnosis and assessment of atrial fibrillation
Dewar, R. I., & Lip, G. Y. H. (2006) · Heart · doi:10.1136/hrt.2006.099861 · Cited by 38
Self-citationPrevalence of atrial fibrillation in Thai elderly.
Phrommintikul, A., Detnuntarat, P., Prasertwitayakij, N., & Wongcharoen, W. (2016) · PubMed Central · doi:10.11909/j.issn.1671-5411.2016.03.002 · Cited by 34
Sharma, S., Gage, B. F., Deych, E., & Rich, M. W. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.03.009 · Cited by 34
Hendrikx, T., Hörnsten, R., Rosenqvist, M., & Sandström, H. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-41 · Cited by 34
Sharma, P., Scotland, G., Cruickshank, M., Tassie, E., Fraser, C. M., Burton, C. D., Croal, B. L., Ramsay, C. R., & Brazzelli, M. G. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007758 · Cited by 39
Uittenbogaart, S. B., Gurp, N. V.-V., Erkens, P. M. G., Lucassen, W. A. M., Knottnerus, J. A., Winkens, B., van Weert, H. C. P. M., & Stoffers, J. (2015) · Trials · doi:10.1186/s13063-015-1006-5 · Cited by 38
Wolfes, J., Ellermann, C., Frommeyer, G., & Eckardt, L. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2302056 · Cited by 34
Jatau, A. I., Peterson, G. M., Bereznicki, L., Dwan, C. A., Black, J. A., Bezabhe, W. M. M., & Wimmer, B. C. (2019) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546819885134 · Cited by 40
Estándares SEA 2022 para el control global del riesgo cardiovascular
Mostaza, J. M., Pintó, X., Armario, P., Masana, L., Real, J. T., Valdivielso, P., Arrobas-Velilla, T., Baeza‐Trinidad, R., Calmarza, P., Cebollada, J., et al. (2022) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.11.003 · Cited by 70
Risk of Bias in Network Meta-Analysis (RoB NMA) tool
Lunny, C., Higgins, J. P. T., White, I. R., Dias, S., Hutton, B., Wright, J. M., Veroniki, A. A., Whiting, P. F., & Tricco, A. C. (2025) · BMJ · doi:10.1136/bmj-2024-079839 · Cited by 41
Omboni, S., & Verberk, W. J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010745 · Cited by 34
Taggar, J., Coleman, T. J., Lewis, S., & Jones, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152086 · Cited by 31
Opportunistic detection of atrial fibrillation using blood pressure monitors: a systematic review
Kane, S. A., Blake, J. R., McArdle, F., Langley, P., & Sims, A. J. (2016) · Open Heart · doi:10.1136/openhrt-2015-000362 · Cited by 34
Hypertensive heart disease in older patients: considerations for clinical practice
Camafort, M., Kasiakogias, A., Agabiti‐Rosei, E., Masi, S., Iliakis, P., Bénétos, A., Jeong, J., Lee, H., Muiesan, M. L., Sudano, I., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.12.034 · Cited by 37
Williams, K. M., Modi, R. N., Dymond, A., Hoare, S. E., Powell, A. E., Burt, J., Edwards, D., Lund, J., Johnson, R., Lobban, T., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-065066 · Cited by 34
Self-citationBarmparas, G., Kobayashi, L. M., Dhillon, N. K., Patel, K., Ley, E. J., Coimbra, R. S. M., & Margulies, D. R. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2018.10.016 · Cited by 29
Proietti, M., Farcomeni, A., Goethals, P., Scavée, C., Vijgen, J. M., Blankoff, I., Vandekerckhove, Y. R., Lip, G. Y. H., Mairesse, G. H., & on behalf of Belgian Heart Rhythm Week Investigators (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319839184 · Cited by 33
Self-citationJowett, S. M., Bryan, S., Mant, J., Fletcher, K., Roalfe, A. K., Fitzmaurice, D. A., Lip, G. Y. H., & Hobbs, R. F. (2011) · Stroke · doi:10.1161/strokeaha.110.600767 · Cited by 28
Self-citationLow prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland
Schmutz, M., Beer‐Borst, S., Meiltz, A., Urban, P. M., Gaspoz, J., Costanza, M. C., Morabia, A., & Zimmermann, M. (2009) · EP Europace · doi:10.1093/europace/eup379 · Cited by 29
Nadarajah, R., Wu, J., Frangi, A. F., Hogg, D., Cowan, C., & Gale, C. P. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052887 · Cited by 33
Smartphone electrocardiogram monitoring: current perspectives
Walker, A., & Muhlestein, J. B. (2018) · Advanced Health Care Technologies · doi:10.2147/ahct.s138445 · Cited by 32
Wolfes, J., Ellermann, C., Frommeyer, G., & Eckardt, L. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.12.018 · Cited by 34
Monteiro, P. F. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.08.006 · Cited by 33
Krummen, D. E., Patel, M. P., Nguyen, H. L., Ho, G., Kazi, D. S., Clopton, P., HOLLAND, M. C., GREENBERG, S. L., Feld, G. K., Faddis, M. N., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01809.x · Cited by 28
Wilson, E., Emery, J. D., Kinmonth, A. L., Prevost, A. T., Morris, H., Humphrys, E., Hall, P. N., Burrows, N., Bradshaw, L. E., Walls, J., et al. (2013) · Value in Health · doi:10.1016/j.jval.2012.12.008 · Cited by 27
“[47] Hobbs FD, Fitzmaurice DA, Man tJ, et al.”
BackgroundVerberk, W. J., & de Leeuw, P. W. (2012) · Expert Review of Medical Devices · doi:10.1586/erd.12.46 · Cited by 29
Improving hearing and vision in dementia: protocol for a field trial of a new intervention
Regan, J. L., Dawes, P., Pye, A., Armitage, C. J., Hann, M., Himmelsbach, I., Reeves, D., Simkin, Z., Yang, F. B., & Leroi, I. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018744 · Cited by 26
Quinn, F. R., Gladstone, D. J., Ivers, N. M., Sandhu, R. K., Dolovich, L. R., Ling, A. L. H., Nakamya, J., Ramasundarahettige, C. F., Frydrych, P. A., Henein, S., et al. (2018) · CMAJ Open · doi:10.9778/cmajo.20180001 · Cited by 28
Saraiva, R. M., Pacheco, N. P., Pereira, T. O. D. J. S., da Costa, A. R., de Holanda, M. T., Sangenis, L. H. C., Mendes, F. S. N. S., de Sousa, A. S., Hasslocher‐Moreno, A. M., Xavier, S. S., et al. (2020) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2020.06.003 · Cited by 27
Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland
Moran, P. S., Teljeur, C., Harrington, P., Smith, S. M., Smyth, B., Harbison, J. A., Normand, C. E. M., & Ryan, M. (2016) · Value in Health · doi:10.1016/j.jval.2016.07.007 · Cited by 27
Gloekler, S., Saw, J., Koskinas, K. C., Kleinecke, C., Jung, W., Nietlispach, F., & Meier, B. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.08.049 · Cited by 29
State of the art of mobile health technologies use in clinical arrhythmia care
Sridhar, A. R. M., Cheung, J. W., Lampert, R., Silva, J. N. A., Gopinathannair, R., Sotomonte, J. C., Tarakji, K. G., Fellman, M., Chrispin, J., Varma, N., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00618-4 · Cited by 32
“The SAFE study showed that pulse palpation in older patients in a routine or opportunistic fashion increased overall AF detection 28 .”
Atrial fibrillation and stroke prevention
Kakar, P., & Lip, G. Y. H. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.10.1523 · Cited by 25
Self-citationHeron, N., Kee, F., Mant, J., Cupples, M., & Donnelly, M. (2019) · British Journal of General Practice · doi:10.3399/bjgp19x705509 · Cited by 26
Self-citationHill, N. R., Groves, L., Dickerson, C., Boyce, R., Lawton, S., Hurst, M. A., Pollock, K. G., Sugrue, D., Lister, S., Arden, C., et al. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2102355 · Cited by 30
Duarte, R. V., Stainthorpe, A., Greenhalgh, J., Richardson, M., Nevitt, S. J., Mahon, J., Kotas, E., Boland, A., Thom, H. H. Z., Marshall, T. P., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24030 · Cited by 32
Are adverse effects incorporated in economic models? An initial review of current practice
Craig, D., McDaid, C., Fonseca, T., Stock, C., Duffy, S., & Woolacott, N. F. (2009) · Health Technology Assessment · doi:10.3310/hta13620 · Cited by 25
Estándares SEA 2019 para el control global del riesgo cardiovascular
Mostaza, J. M., Pintó, X., Armario, P., Masana, L., Ascaso, J. F., Valdivielso, P., Velilla, T. A., Brea, Á., Calmarza, P., Cebollada, J., et al. (2019) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2019.03.004 · Cited by 61
Hill, N. R., Arden, C., BERESFORD-HULME, L. M., Camm, A. J., Clifton, D. A., Davies, D. W., Farooqui, U., Gordon, J. P., Groves, L., Hurst, M. A., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106191 · Cited by 24
Oguz, M., Lanitis, T., Li, X., Wygant, G. D., Singer, D. E., Friend, K. E., Hlavacek, P., Nikolaou, A., & Mattke, S. (2019) · Applied Health Economics and Health Policy · doi:10.1007/s40258-019-00542-y · Cited by 26
Burdett, P., & Lip, G. Y. H. (2022) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcac005 · Cited by 24
Self-citationBarra, S., & Fynn, S. P. (2014) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2014.08.002 · Cited by 28
Smart watch applications in atrial fibrillation detection: Current state and future directions
Vyas, R., Jain, S., Thakre, A., Thotamgari, S. R., Raina, S., Brar, V., Sengupta, P. P., & Agrawal, P. K. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16451 · Cited by 33
“15 18 – 20 Continuous monitoring devices offer the advantage of recording data over weeks to years, providing greater sensitivity for detecting Afib, 21 emphasizing the preference for continuous ECG ‐ based monitoring devices for diagnosing paroxysmal Afib.”
Large‐scale screening studies for atrial fibrillation – is it worth the effort?
Engdahl, J., & Rosenqvist, M. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13217 · Cited by 23
Szymanski, T., Ashton, R., Sekelj, S., Petrungaro, B., Pollock, K. G., Sandler, B., Lister, S., Hill, N. R., & Farooqui, U. (2022) · EP Europace · doi:10.1093/europace/euac016 · Cited by 22
Sharples, L. D., Everett, C., Singh, J., Mills, C., Spyt, T. J., Abu-Omar, Y., Fynn, S. P., Thorpe, B., Stoneman, V. E. A., Goddard, H., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22190 · Cited by 26
Utility of risk prediction models to detect atrial fibrillation in screened participants
Poorthuis, M. H. F., Jones, N. R., Sherliker, P., Clack, R. M., de Borst, G. J., Clarke, R., Lewington, S., Halliday, A. W., & Bulbulia, R. A. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa082 · Cited by 25
Is primary care research important and relevant to GPs?
Hobbs, R. F. (2019) · British Journal of General Practice · doi:10.3399/bjgp19x705149 · Cited by 24
Bimodal classification algorithm for atrial fibrillation detection from m-health ECG recordings
Kruger, G. H., Latchamsetty, R., Langhals, N. B., Yokokawa, M., Chugh, A., Morady, F., Oral, H., & Berenfeld, O. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.11.016 · Cited by 21
da Costa, F. A., Malá‐Ládová, K., Lee, V. W. Y., Tous, S., Papastergiou, J., Griffiths, D., Chaumais, M., Hersberger, K. E., Viola, R., Paulino, E., et al. (2019) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-019-02000-x · Cited by 23
Groenewegen, A., Zwartkruis, V. W., Rienstra, M., Hollander, M., Koffijberg, H., Cramer, M. J., van der Schouw, Y. T., Hoes, A. W., de Boer, R. A., & Rutten, F. H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046330 · Cited by 24
Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study
Fitzmaurice, D. A., McCahon, D., Baker, J., Murray, E. T., Jowett, S. M., Sandhar, H., Holder, R. L., & Hobbs, R. F. (2014) · Family Practice · doi:10.1093/fampra/cmu011 · Cited by 21
Self-citationFay, M., Fitzmaurice, D. A., & Freedman, B. (2017) · European Journal of General Practice · doi:10.1080/13814788.2017.1374366 · Cited by 24
Self-citationKollias, A., Destounis, A., Kalogeropoulos, P., Kyriakoulis, K. G., Ntineri, A., & Stergiou, G. S. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10797 · Cited by 21
Genetic basis of atrial fibrillation
Hong, K., & Xiong, Q. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000051 · Cited by 23
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.20200446 · Cited by 28
Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation
Cohen, D. J., Wang, K., Magnuson, E. A., Smith, R., Petrie, M. C., Buch, M. H., Abraham, W. T., Lindenfeld, J. M., Mack, M. J., Stone, G. W., et al. (2022) · Heart · doi:10.1136/heartjnl-2021-320005 · Cited by 21
Aronsson, M., Svennberg, E., Rosenqvist, M., Engdahl, J., Al‐Khalili, F., Friberg, L., Frykman, V., & Levin, L. (2017) · EP Europace · doi:10.1093/europace/eux002 · Cited by 23
Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
Nashef, S. A. M., Fynn, S. P., Abu-Omar, Y., Spyt, T. J., Mills, C., Everett, C., Fox-Rushby, J. A., Singh, J., Dalrymple-Hay, M. J. R., Sudarshan, C., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy165 · Cited by 22
Should we screen for atrial fibrillation?
Lown, M. T., & Moran, P. S. (2019) · BMJ · doi:10.1136/bmj.l43 · Cited by 22
Savickas, V., Stewart, A. J., Rees-Roberts, M., Short, V., Bhamra, S. K., Corlett, S. A., Mathie, A. A., & Veale, E. L. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003197 · Cited by 27
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020
Orozco‐Beltrán, D., Cuixart, C. B., Sánchez, J. J. A., Banegas, J. R., Cuenca, A. M. C., Gil-Guillén, V. F., Rioboó, E. M., & Pérez, J. N. (2020) · Atención Primaria · doi:10.1016/j.aprim.2020.08.002 · Cited by 30
Deep learning evaluation of echocardiograms to identify occult atrial fibrillation
Yuan, N., Stein, N. R., Duffy, G., Sandhu, R. K., Chugh, S. S., Chen, P., Rosenberg, C., Albert, C. M., Cheng, S. C., Siegel, R. J., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01090-z · Cited by 23
Lip, G. Y. H., Potpara, T., Boriani, G., & Blomström‐Lundqvist, C. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12468 · Cited by 23
Self-citationDuning, T., Kirchhof, P. F., Wersching, H., Hepp, T., & Reinhardt, R. (2011) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000123 · Cited by 18
Towers, A., Rand, S. E., Allan, S., Webster, L., Palmer, S., Carroll, R. E., Gordon, A. L., Akdur, G., Smith, N., Burton, J. K., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090684 · Cited by 22
Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines
Kirchhof, P. F. (2017) · Heart · doi:10.1136/heartjnl-2016-310843 · Cited by 21
Zhang, G., Zhang, K., Zheng, X., Cui, W., Hong, Y., & Zhang, Z. (2019) · Emergency Medicine Journal · doi:10.1136/emermed-2019-208901 · Cited by 19
Ho, I., Wong, C., Wong, Y., Lam, T.-H., Leung, I. S. H., Lin, M., Lui, D. T. W., Kwok, W. C., Tam, C. C., Chan, Y., et al. (2023) · JACC Asia · doi:10.1016/j.jacasi.2023.09.014 · Cited by 18
JCS / JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia
Takase, B., Ikeda, T., Shimizu, W., Abe, H., Aiba, T., Chinushi, M., Koba, S., KUSANO, K. F., Niwano, S., Takahashi, N., et al. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13052 · Cited by 23
Diving to the foot of an iceberg: The SEARCH for undiagnosed atrial fibrillation
Lane, D. A., & Potpara, T. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-05-0437 · Cited by 19
Atrial Fibrillation in the Elderly: A Review
Hakim, F. A., & Shen, W.-K. (2014) · Future Cardiology · doi:10.2217/fca.14.32 · Cited by 20
Prevention of cardiovascular disease in modern China: Utile or futile?
Cheng, T. O. (2009) · Global Heart · doi:10.1016/j.cvdpc.2008.11.002 · Cited by 17
Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012
Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., Baumgartner, H., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.11.001 · Cited by 27
Self-citationCollaborative Group DOFA-AP, Pérula-de-Torres, L., Martínez-Adell, M., González-Blanco, V., Baena-Díez, J. M., Martín-Rioboó, E., Rejano, J. M. P., González-Lama, J., Álvarez, R. M., Moral, R. R., et al. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-106 · Cited by 16
“There is evidence that the opportunistic option is the most appropriate [27].”
Background
Metadata
- Authors
- Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G.
- Affiliations
- University of Birmingham (GB)
- Selly Oak Hospital (GB)
- Birmingham City Hospital (GB)
- Venue
- Health Technology Assessment
- Published
- 2005-10
- Volume
- 9
- Issue
- 40
- Pages
- iii-iv, ix
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2018796325
- Semantic Scholar
- 6a762d2e553123cd54cf721ab5362f51c0e3da53
- Cited by
- 437
- References
- 60
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 24 · 2023: 17 · 2022: 32 · 2021: 27 · 2020: 35 · 2019: 27 · 2018: 34 · 2017: 25 · 2016: 31 · 2015: 23 · 2014: 27 · 2013: 26 · 2012: 18
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ePrints Soton (University of Southampton) (submittedVersion)
- Apollo
- Funders
- Health Technology Assessment programme (96/22/11)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- atrial fibrillation, systematic screening, opportunistic screening, targeted screening, cost-effectiveness, ECG interpretation, irregular pulse, atrial fibrillation prevalence, atrial fibrillation incidence, older adults, primary care, atrial fibrillation risk factors, practice nurses, general practitioners, atrial fibrillation mortality
- MeSH terms
- Aged, Atrial Fibrillation, Cost-Benefit Analysis, Electrocardiography, Female, United Kingdom, Humans, Male, Mass Screening, Primary Health Care, Risk Factors, Incidence, Prevalence, Outcome Assessment, Health Care, Sample Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.